Cargando…
Dual blockade of the lipid kinase PIP4Ks and mitotic pathways leads to cancer-selective lethality
Achieving robust cancer-specific lethality is the ultimate clinical goal. Here, we identify a compound with dual-inhibitory properties, named a131, that selectively kills cancer cells, while protecting normal cells. Through an unbiased CETSA screen, we identify the PIP4K lipid kinases as the target...
Autores principales: | Kitagawa, Mayumi, Liao, Pei-Ju, Lee, Kyung Hee, Wong, Jasmine, Shang, See Cheng, Minami, Noriaki, Sampetrean, Oltea, Saya, Hideyuki, Lingyun, Dai, Prabhu, Nayana, Diam, Go Ka, Sobota, Radoslaw, Larsson, Andreas, Nordlund, Pär, McCormick, Frank, Ghosh, Sujoy, Epstein, David M., Dymock, Brian W., Lee, Sang Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736559/ https://www.ncbi.nlm.nih.gov/pubmed/29259156 http://dx.doi.org/10.1038/s41467-017-02287-5 |
Ejemplares similares
-
Modeling phenotypes of malignant gliomas
por: Sampetrean, Oltea, et al.
Publicado: (2017) -
An efficient proteome-wide strategy for discovery and characterization of cellular nucleotide-protein interactions
por: Lim, Yan Ting, et al.
Publicado: (2018) -
Lactate Reprograms Energy and Lipid Metabolism in Glucose-Deprived Oxidative Glioma Stem Cells
por: Minami, Noriaki, et al.
Publicado: (2021) -
Mad2 inhibits the mitotic kinesin MKlp2
por: Lee, Sang Hyun, et al.
Publicado: (2010) -
PIP4Ks Suppress Insulin Signaling through a Catalytic-Independent Mechanism
por: Wang, Diana G., et al.
Publicado: (2019)